Expression levels of membrane-bound tumor necrosis factor alpha receptors in active tuberculosis and healthy individuals

A. Alshevskaya, F. Kireev, J. Lopatnikova, Z. Laushkina, S. Sennikov (Novosibirsk, Russian Federation)

Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Session: Diagnostic features of tuberculosis I
Session type: Thematic Poster Session
Number: 2781

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Alshevskaya, F. Kireev, J. Lopatnikova, Z. Laushkina, S. Sennikov (Novosibirsk, Russian Federation). Expression levels of membrane-bound tumor necrosis factor alpha receptors in active tuberculosis and healthy individuals. Eur Respir J 2013; 42: Suppl. 57, 2781

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016

The role of toll like receptors on tuberculosis infection
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013


Latent tuberculosis screening and entering antibody therapy monoclonares against tumor necrosis factor
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Genetic polymorphism in the human tumor necrosis factor (TNF) and its association with different clinical types of tuberculosis disease in Peruvian patients
Source: Eur Respir J 2004; 24: Suppl. 48, 467s
Year: 2004

Differential diagnostic efficiency of T cells subsets versus interferon-gamma, tumor necrosis factor alpha and adenosine deaminase in distinguishing tuberculous from malignant pleural effusions
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Radiographic changes in patients with tumor necrosis factor alpha inhibitor and immunomodulatory drug users: Four years follow up
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016

Feasibility of bronchoscopy obtained tissue for tumor diagnosis and testing epidermal growth factor receptor (EGFR) mutational status
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Source: Eur Respir J 2010; 36: 1185-1206
Year: 2010



Screening for latent tuberculosis before tumour necrosis factor antagonist therapy
Source: Eur Respir J 2015; 45: 1512-1513
Year: 2015


Screening for latent tuberculosis before tumour necrosis factor antagonist therapy
Source: Eur Respir J 2015; 45: 1510-1512
Year: 2015


CD27 expression as a new tool to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015


CD8-response associates with active tuberculosis and TB2-tube response in the QuantiFERON-TB-Plus kit
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Serum cytokines level can differentiate active pulmonary tuberculosis from latent TB
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013


Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011

Tuberculosis and tumor necrosis factor alpha antagonist: Our experience
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012

Miliary tuberculosis during treatment with anti TNF alpha - a report of four cases
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Tumor necrosis factor alpha inhibitors and reactivation of tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 281s
Year: 2007

T cell and B cell immunological responses by tuberculous antigens in Japanese populations with different bacterial antigen expressions
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013

Use of interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1Ra) contents in alveolar macrophages for estimation of inflammation activity in patients with different levels of asthma control
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013